Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Lantern Pharma highlights AI-powered cancer research platforms during UNT’s first AI for Biology & Medicine symposium Find out how Lantern Pharma is redefining AI-driven cancer drug development with predictBBB.ai and LBx-AI at UNT’s inaugural AI4BM symposium. bySoujanya RaviOctober 30, 2025